CLINICAL_TRIALS
trial_result
· 2023-07-25
Clinical Trial Update: Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma [Phase 4]
Summary
Phase 4 trial investigating anlotinib in patients with advanced medullary thyroid carcinoma is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Medullary Thyroid Cancer | Phase 4 | Status: RECRUITING